وبلاگ بلیان

داروشناسی نظارتی: نقد و راه‌های پیش رو

Pharmacovigilance : Critique and Ways Forward

معرفی کتاب «داروشناسی نظارتی: نقد و راه‌های پیش رو» (با عنوان لاتین Pharmacovigilance : Critique and Ways Forward) نوشتهٔ I. Ralph Edwards, Marie Lindquist (eds.)، منتشرشده توسط نشر Adis در سال 2017. این کتاب در فرمت pdf، زبان انگلیسی ارائه شده است.

Written by experienced authors, this book offers expert personal views on what the current problems in pharmacovigilance are and how they should be solved. This book stems from thoughts and ideas discussed in a series of meetings of the International Society of Pharmacovigilance (ISoP), where concerns were raised that the current pharmacovigilance system is not delivering optimally to improve therapeutics in clinical practice. Pharmacovigilance of the future must be an active and integral part of health care delivery, and focus more on science and practices that support health professionals and patients in day-to-day care situations. To achieve this, a dynamic and sustainable development of vigilance must take precedence over the current excessive preoccupations with data processing and regulations; all aspects of medicines use and their effects need to be considered; and all stakeholders must be involved and engaged in an open and constructive debate. The work is essential reading for anyone who has an interest in safer use of medicines. It is intended to be equally challenging and rewarding, and sets out to stimulate a continuous debate on how pharmacovigilance can better meet the needs of health professionals and patients to achieve the aim of wise therapeutic decision making. Front Matter....Pages i-xxxi Teaching Pharmacovigilance in University....Pages 1-8 Lost in Regulation....Pages 9-19 What Is the Future of Pharmacovigilance and How Can We Make It as Good as Possible? ....Pages 21-30 Some Other Ideas About the Future of Pharmacovigilance....Pages 31-33 Best Safety Practices Now and in the Future....Pages 35-48 Is There a Benefit from the Medical Literature Monitoring Service of the EMA?....Pages 49-53 The Unified Drug Safety-Clinical Database....Pages 55-66 Behind the Scenes: ‘Silent Factors’ Influencing Pharmacovigilance Practice and Decisions....Pages 67-79 Shaking Up Culture and Communication in PV [V6]....Pages 81-97 Pharmacovigilance Indicators: Desiderata for the Future of Medicine Safety....Pages 99-114 Thoughts on Pharmacovigilance in the Future: There Are More Weber-Effects....Pages 115-120 Effective Treatment Matters: Revitalizing Pharmacovigilance....Pages 121-130 Broadening the Scope of Pharmacovigilance....Pages 131-144 Herbal and Traditional Medicines, Now and Future....Pages 145-159 The Concept of ‘Health’....Pages 161-172 Impact of Referral Procedures on the Interaction of RMP and PSUR....Pages 173-179 Other Sources of Information for Monitoring Drug Safety: Now and in the Future....Pages 181-193 Ecopharmacovigilance....Pages 195-205
دانلود کتاب داروشناسی نظارتی: نقد و راه‌های پیش رو